HIGHLIGHTS
- who: Paul Walker from the (UNIVERSITY) have published the paper: Liquid Biopsy and the Translational Bridge from the TIME to the Clinic, in the Journal: Cells 2022, 11, 3114. of /2022/
- what: As a clinical oncologist the purpose of this is to emphasize the importance of researching and improving clinical utility of the bridge as well as the TIME research itself. The optimal make-up and balance of a composite TIME/ICI predictive liquid biopsy assay is one important research focus.
- future: Research into expanding the clinical utility development of a composite TIME . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.